Home›Stock Screener›Dr. Agarwal's Health Care›Financial Statements

Dr. Agarwal's Health Care Complete Financial Statements

7 Years of Data
2026 - 2020

In FY2026, Dr. Agarwal's Health Care (AGARWALEYE) reported revenue ₹578 Cr, net profit ₹50 Cr and EPS ₹1.25, with a net profit margin of 8.7% and ROE of 2.5%. Full financial statements from FY2020 to FY2026 (7 years) — income statement, balance sheet and cash flow in ₹ Crores. Download as Excel or CSV. Examine AGARWALEYE earnings report for recent quarterly revenue, profit and EPS trends.

Complete Financial Data Export

Profitability Ratios

Net Profit Margin 8.65% 2026 data
EBITDA Margin 30.28% 2026 data
Operating Margin 29.00% 2026 data
Return on Assets 1.27% 2026 data
Return on Equity 2.47% 2026 data

Balance Sheet Ratios

Current Ratio 0.42 2026 data
Equity Ratio 51.40% 2026 data
Asset Turnover 0.15 2026 data

AGARWALEYE Revenue, Net Profit & EBITDA — Year-on-Year Growth

AGARWALEYE YoY (Mar 2025 vs Mar 2026) — revenue +21.4%, net profit +16.3%, EBITDA +21.5%, expenses +21.4%. For live price, earnings ratios and company overview, see AGARWALEYE share price.

Revenue Growth
+21.4%
Year-over-Year
Net Profit Growth
+16.3%
Year-over-Year
EBITDA Growth
+21.5%
Year-over-Year
Expense Growth
+21.4%
Year-over-Year
Assets Growth
+7.4%
Year-over-Year
Equity Growth
+5.1%
Year-over-Year
Operating Cash Flow Growth
+4.0%
Year-over-Year
Investing Cash Flow Growth
+17.9%
Year-over-Year
Financing Cash Flow Growth
-30.9%
Year-over-Year

AGARWALEYE Income Statement — Revenue, EBITDA & Net Profit

Dr. Agarwal's Health Care revenue ₹578 Cr, EBITDA ₹175 Cr, net profit ₹50 Cr, EPS ₹1.25 (2026) — net profit margin 8.7%. Analyse AGARWALEYE FII DII holdings to track promoter, FII and institutional holdings.

Periods ₹ Crores
Particulars Mar 2026 Sept 2025 Mar 2025 Jun 2025 Dec 2025 Sept 2024 Mar 2024 Jun 2024 Dec 2024 Dec 2023
Revenue 578 507 476 501 540 429 369 410 443 345
Expenses 403 363 332 360 386 310 241 300 316 244
EBITDA 175 144 144 141 155 119 128 110 128 101
Operating Profit Margin % 29.00% 27.00% 28.00% 26.00% 27.00% 26.00% 31.00% 26.00% 27.00% 27.00%
Depreciation 77 68 60 63 69 57 47 56 58 43
Interest 22 23 25 25 21 28 27 27 28 22
Profit Before Tax 77 54 59 54 65 33 54 27 41 36
Tax 27 17 16 16 21 12 13 9 13 13
Net Profit 50 37 43 38 44 21 41 18 28 23
Earnings Per Share (₹) 1.25 0.94 1.04 0.95 1.07 0.45 1.39 0.43 0.73 1.94

AGARWALEYE Balance Sheet — Assets, Liabilities & Shareholders' Equity

AGARWALEYE total assets ₹3,942 Cr, total equity ₹2,026 Cr, total liabilities ₹ Cr (2026) — ROE 2.5%.

Years Annual Data ₹ Crores
Particulars 2026 2025 2024 2023 2022 2021 2020
ASSETS
Total Assets 3,942 3,672 2,753 1,825 1,026 787 752
Current Assets 573 794 759 310 228 155 146
Fixed Assets 2,378 2,523 1,746 1,293 702 575 551
Capital Work in Progress 234 153 118 99 28 11 8
Investments 94 264 471 34 0 0 1
Other Assets 0 731 418 399 296 201 193
LIABILITIES
Total Liabilities
Current Liabilities 1,361 1,267 974 865 586 438 339
Non-Current Liabilities
SHAREHOLDERS' EQUITY
Total Equity 2,026 1,927 1,380 659 234 199 267
Share Capital 32 32 9 8 7 7 7
Reserves & Surplus 1,994 1,835 1,330 622 206 177 242

AGARWALEYE Cash Flow Statement — Operating, Investing & Financing

Dr. Agarwal's Health Care operating cash flow ₹360 Cr, investing ₹-750 Cr, financing ₹382 Cr, net cash flow ₹-8 Cr (2025).

Periods ₹ Crores
Particulars March 2025 March 2024 March 2023 March 2022 March 2021 March 2020
Operating Activities 360 346 233 164 99 103
Investing Activities -750 -914 -509 -155 -46 -85
Financing Activities 382 553 303 35 -37 -74
Net Cash Flow -8 -15 27 44 17 -56